Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HBV Vaccination, HCC Prevention Taiwan

Mei-Hwei Chang

MD

🏢National Taiwan University🌐Taiwan

Professor

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Mei-Hwei Chang led the landmark Taiwan hepatitis B vaccination program starting in 1984 — and demonstrated decades later that universal infant HBV vaccination dramatically reduced liver cancer (HCC) incidence in the vaccinated generation. This is the first example of a vaccination program demonstrably reducing cancer incidence at the population level, establishing proof-of-concept that vaccines can prevent virus-associated cancers and inspiring broader cancer prevention vaccination efforts.

Share:

🧪Research Fields 研究领域

hepatitis B vaccine HCC prevention
HBV vaccination Taiwan program
HCC incidence reduction HBV vaccine
pediatric HBV vaccination cancer prevention
liver cancer prevention vaccination

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Mei-Hwei Chang 的研究动态

Follow Mei-Hwei Chang's research updates

留下邮箱,当我们发布与 Mei-Hwei Chang(National Taiwan University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment